Article
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.
Histopathology - 1 Apr 2024
Grillo Federica, Paudice Michele, Pigozzi Simona, Dono Maria, Lastraioli Sonia, Lugaresi Marialuisa, Bozzano Silvia, Tognoni Camilla, Ali Murad, Sciallero Stefania, Puccini Alberto, Fassan Matteo, Mastracci Luca
Abstract excerpt
AIMS: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS-associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAFV600E IHC and BRAF molecular analysis in a large, mono-institutional CRC whole-slide, case series with laboratory...
Topics
- Humans
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Immunohistochemistry
- Proto-Oncogene Proteins B-raf
- Early Detection of Cancer
- Colorectal Neoplasms
- Molecular Diagnostic Techniques
- Algorithms
- DNA Mismatch Repair
